Merck & Co.
Sign in to saveAlso known as MSD, Merck Sharp & Dohme, Merck Sharp & Dohme Corp.
American multinational pharmaceutical company
OverviewAI-generated
Merck & Co., Inc. is an active pharmaceutical company established in 1891. The organization operates under the acronym MSD and has its legal name registered as MERCK & CO., INC. It is located in Rahway, New Jersey, United States. The entity type is classified as an operating company within the industry of Pharmaceutical Preparations.
The firm trades on the NYSE under the ticker symbol MRK, with a fiscal year ending on December 31. Financial data indicates total revenue of 64168000000 and total assets of 95377000000. The company reports a market capitalization of 178400000000, net profit of 17117000000, and operating income of 19936000000. It employs 70000 people.
Synthesized by Vinony from 39 facts across 6 sources: Wikidata, Firecrawl, GLEIF, SEC EDGAR, ROR, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Company type
- Public
- Traded as
- NYSE : MRK DJIA component S&P 100 component S&P 500 component
- Industry
- Pharmaceuticals
- Founded
- January 1891 ; 135 years ago ( 1891-01 ) , as a subsidiary of Merck 1917 ; 109 years ago ( 1917 ) , as an independent company
- Founders
- Theodore Weicker George Merck
- Headquarters
- Rahway, New Jersey , U.S.
- Area served
- Worldwide
- Key people
- Robert M. Davis ( chairman , president and CEO ) Caroline Litchfield ( CFO ) Dean Y. Li (president, Merck Research Laboratories)
- Products
- Pharmaceuticals generic drugs over-the-counter drugs vaccines diagnostics Veterinary medicine
- Revenue
- US$ 65.01 billion (2025)
- Operating income
- US$21.22 billion (2025)
- Net income
- US$18.25 billion (2025)
- Total assets
- US$136.9 billion (2025)
- Total equity
- US$52.61 billion (2025)
- Number of employees
- c. 75,000 (2025)
- Website
- merck .com (US & Canada) msd .com (international)
via Wikipedia infobox
Company
MRK- Industry
- Pharmaceutical Preparations
- Exchange
- NYSE
- State of incorporation
- NJ
- Entity type
- operating
- Jurisdiction
- US-NJ
- Headquarters
- Rahway, US
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1891
- Location
- Rahway, United States
- Also known as
- MSD, MSD United States
- Status
- Active
GRID grid.417993.1 · ISNI 0000 0001 2260 0793
Wikidata facts
- Instance of
- pharmaceutical company
- Part of
- Dow Jones Industrial Average
- Country
- United States
- Headquarters
- Rahway
- Owned by
- BlackRock
- Industry
- pharmaceutical industry
- Employees
- 70000
- Revenue
- 64168000000
- Stock exchange
- New York Stock Exchange
- Follows
- Schering-Plough
- Official website
- www.msd.no
- Image
- Merck office Upper Gwynedd Township Montgomery County.jpg
Show 10 more facts
- inception
- 1891-01-01
- product or material produced
- Gardasil
- total assets
- 95377000000
- market capitalization
- 178400000000
- Commons category
- Merck & Co., Inc.
- topic's main category
- Category:Merck & Co.
- different from
- Merck KGaA
- social media followers
- 225759
- net profit
- 17117000000
- operating income
- 19936000000
Sources (15)
via Wikidata · CC0
~37 min read
Encyclopedic overview
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda (pembrolizumab), a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
Excerpted from Wikipedia’s “Merck & Co.” article, available under the CC BY-SA 4.0 licence.